Home > Research > Publications & Outputs > The effect of trauma-focused therapy on the alt...
View graph of relations

The effect of trauma-focused therapy on the altered T cell distribution in individuals with PTSD: Evidence from a randomized controlled trial

Research output: Contribution to Journal/MagazineJournal articlepeer-review

Published

Standard

The effect of trauma-focused therapy on the altered T cell distribution in individuals with PTSD: Evidence from a randomized controlled trial. / Morath, J.; Gola, H.; Sommershof, A. et al.
In: Journal of Psychiatric Research, Vol. 54, 01.07.2014, p. 1-10.

Research output: Contribution to Journal/MagazineJournal articlepeer-review

Harvard

Morath, J, Gola, H, Sommershof, A, Hamuni, G, Kolassa, S, Catani, C, Adenauer, H, Ruf-Leuschner, M, Schauer, M, Elbert, T, Groettrup, M & Kolassa, I-T 2014, 'The effect of trauma-focused therapy on the altered T cell distribution in individuals with PTSD: Evidence from a randomized controlled trial', Journal of Psychiatric Research, vol. 54, pp. 1-10. https://doi.org/10.1016/j.jpsychires.2014.03.016

APA

Morath, J., Gola, H., Sommershof, A., Hamuni, G., Kolassa, S., Catani, C., Adenauer, H., Ruf-Leuschner, M., Schauer, M., Elbert, T., Groettrup, M., & Kolassa, I.-T. (2014). The effect of trauma-focused therapy on the altered T cell distribution in individuals with PTSD: Evidence from a randomized controlled trial. Journal of Psychiatric Research, 54, 1-10. https://doi.org/10.1016/j.jpsychires.2014.03.016

Vancouver

Morath J, Gola H, Sommershof A, Hamuni G, Kolassa S, Catani C et al. The effect of trauma-focused therapy on the altered T cell distribution in individuals with PTSD: Evidence from a randomized controlled trial. Journal of Psychiatric Research. 2014 Jul 1;54:1-10. doi: 10.1016/j.jpsychires.2014.03.016

Author

Morath, J. ; Gola, H. ; Sommershof, A. et al. / The effect of trauma-focused therapy on the altered T cell distribution in individuals with PTSD : Evidence from a randomized controlled trial. In: Journal of Psychiatric Research. 2014 ; Vol. 54. pp. 1-10.

Bibtex

@article{c1de5b900b35456b98a77e406ecd16fc,
title = "The effect of trauma-focused therapy on the altered T cell distribution in individuals with PTSD: Evidence from a randomized controlled trial",
abstract = "Posttraumatic stress disorder (PTSD) is associated with a reduced ratio of na{\"i}ve cytotoxic T lymphocytes, an increased ratio of memory cytotoxic T lymphocytes, and a reduced proportion of FoxP3+ regulatory T lymphocytes. This study investigated whether these immunological alterations are reversible through an evidence-based psychotherapeutic treatment. Therefore, 34 individuals with PTSD were randomly assigned to either a treatment condition of 12 sessions narrative exposure therapy (NET) or a waitlist control (WLC) group. PTSD symptoms were significantly reduced in the NET group, but not in the WLC group, four months post-therapy (effect size: Hedges' g = −1.61). One year after therapy, PTSD symptoms were improved even further in the NET group compared to baseline (Hedges' g = −1.96). This symptom improvement was mirrored in an increase in the originally reduced proportion of regulatory T cells (Tregs) in the NET group at the one-year follow-up, when comparing subgroups matched for baseline Treg numbers. However, no changes were found for the initially reduced proportion of CD45RA+CCR7+ na{\"i}ve T lymphocytes. In conclusion, NET was effective in reducing trauma-related PTSD symptoms and had a positive effect on the proportion of Tregs cells, thus demonstrating an effect of psychotherapy on an immunological level. Yet, the shift in the proportion of na{\"i}ve and memory T lymphocytes in individuals with PTSD, discussed in the literature as a correlate of premature immunosenescence, was not reversible and thus might render these patients permanently more susceptible to infectious diseases.",
author = "J. Morath and H. Gola and A. Sommershof and G. Hamuni and S. Kolassa and C. Catani and H. Adenauer and M. Ruf-Leuschner and M. Schauer and T. Elbert and M. Groettrup and I.-T. Kolassa",
year = "2014",
month = jul,
day = "1",
doi = "10.1016/j.jpsychires.2014.03.016",
language = "English",
volume = "54",
pages = "1--10",
journal = "Journal of Psychiatric Research",
issn = "0022-3956",
publisher = "Elsevier Limited",

}

RIS

TY - JOUR

T1 - The effect of trauma-focused therapy on the altered T cell distribution in individuals with PTSD

T2 - Evidence from a randomized controlled trial

AU - Morath, J.

AU - Gola, H.

AU - Sommershof, A.

AU - Hamuni, G.

AU - Kolassa, S.

AU - Catani, C.

AU - Adenauer, H.

AU - Ruf-Leuschner, M.

AU - Schauer, M.

AU - Elbert, T.

AU - Groettrup, M.

AU - Kolassa, I.-T.

PY - 2014/7/1

Y1 - 2014/7/1

N2 - Posttraumatic stress disorder (PTSD) is associated with a reduced ratio of naïve cytotoxic T lymphocytes, an increased ratio of memory cytotoxic T lymphocytes, and a reduced proportion of FoxP3+ regulatory T lymphocytes. This study investigated whether these immunological alterations are reversible through an evidence-based psychotherapeutic treatment. Therefore, 34 individuals with PTSD were randomly assigned to either a treatment condition of 12 sessions narrative exposure therapy (NET) or a waitlist control (WLC) group. PTSD symptoms were significantly reduced in the NET group, but not in the WLC group, four months post-therapy (effect size: Hedges' g = −1.61). One year after therapy, PTSD symptoms were improved even further in the NET group compared to baseline (Hedges' g = −1.96). This symptom improvement was mirrored in an increase in the originally reduced proportion of regulatory T cells (Tregs) in the NET group at the one-year follow-up, when comparing subgroups matched for baseline Treg numbers. However, no changes were found for the initially reduced proportion of CD45RA+CCR7+ naïve T lymphocytes. In conclusion, NET was effective in reducing trauma-related PTSD symptoms and had a positive effect on the proportion of Tregs cells, thus demonstrating an effect of psychotherapy on an immunological level. Yet, the shift in the proportion of naïve and memory T lymphocytes in individuals with PTSD, discussed in the literature as a correlate of premature immunosenescence, was not reversible and thus might render these patients permanently more susceptible to infectious diseases.

AB - Posttraumatic stress disorder (PTSD) is associated with a reduced ratio of naïve cytotoxic T lymphocytes, an increased ratio of memory cytotoxic T lymphocytes, and a reduced proportion of FoxP3+ regulatory T lymphocytes. This study investigated whether these immunological alterations are reversible through an evidence-based psychotherapeutic treatment. Therefore, 34 individuals with PTSD were randomly assigned to either a treatment condition of 12 sessions narrative exposure therapy (NET) or a waitlist control (WLC) group. PTSD symptoms were significantly reduced in the NET group, but not in the WLC group, four months post-therapy (effect size: Hedges' g = −1.61). One year after therapy, PTSD symptoms were improved even further in the NET group compared to baseline (Hedges' g = −1.96). This symptom improvement was mirrored in an increase in the originally reduced proportion of regulatory T cells (Tregs) in the NET group at the one-year follow-up, when comparing subgroups matched for baseline Treg numbers. However, no changes were found for the initially reduced proportion of CD45RA+CCR7+ naïve T lymphocytes. In conclusion, NET was effective in reducing trauma-related PTSD symptoms and had a positive effect on the proportion of Tregs cells, thus demonstrating an effect of psychotherapy on an immunological level. Yet, the shift in the proportion of naïve and memory T lymphocytes in individuals with PTSD, discussed in the literature as a correlate of premature immunosenescence, was not reversible and thus might render these patients permanently more susceptible to infectious diseases.

U2 - 10.1016/j.jpsychires.2014.03.016

DO - 10.1016/j.jpsychires.2014.03.016

M3 - Journal article

VL - 54

SP - 1

EP - 10

JO - Journal of Psychiatric Research

JF - Journal of Psychiatric Research

SN - 0022-3956

ER -